JP2024521774A5 - - Google Patents
Info
- Publication number
- JP2024521774A5 JP2024521774A5 JP2023572737A JP2023572737A JP2024521774A5 JP 2024521774 A5 JP2024521774 A5 JP 2024521774A5 JP 2023572737 A JP2023572737 A JP 2023572737A JP 2023572737 A JP2023572737 A JP 2023572737A JP 2024521774 A5 JP2024521774 A5 JP 2024521774A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- membered
- alkyl
- hydrogen
- bonded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192837P | 2021-05-25 | 2021-05-25 | |
| US63/192,837 | 2021-05-25 | ||
| PCT/US2022/030823 WO2022251292A1 (en) | 2021-05-25 | 2022-05-25 | Methods for inhibiting ras |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521774A JP2024521774A (ja) | 2024-06-04 |
| JP2024521774A5 true JP2024521774A5 (https=) | 2025-06-02 |
Family
ID=82115695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572737A Pending JP2024521774A (ja) | 2021-05-25 | 2022-05-25 | Ｒａｓの阻害方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240277796A1 (https=) |
| EP (1) | EP4346898A1 (https=) |
| JP (1) | JP2024521774A (https=) |
| KR (1) | KR20240026526A (https=) |
| CN (2) | CN118557730A (https=) |
| AU (1) | AU2022281343A1 (https=) |
| CA (1) | CA3219533A1 (https=) |
| IL (1) | IL308771A (https=) |
| MX (1) | MX2023013912A (https=) |
| TW (1) | TW202313631A (https=) |
| WO (1) | WO2022251292A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202132316A (zh) | 2019-11-04 | 2021-09-01 | 美商銳新醫藥公司 | Ｒａｓ抑制劑 |
| CA3194067A1 (en) | 2020-09-15 | 2022-03-24 | Revolution Medicines, Inc. | Ras inhibitors |
| KR20240017811A (ko) | 2021-05-05 | 2024-02-08 | 레볼루션 메디슨즈, 인크. | 암의 치료를 위한 ras 억제제 |
| AR127308A1 (es) | 2021-10-08 | 2024-01-10 | Revolution Medicines Inc | Inhibidores ras |
| CN118922423A (zh) * | 2022-01-10 | 2024-11-08 | 锐新医药公司 | Ras抑制剂 |
| JP2025519199A (ja) * | 2022-06-01 | 2025-06-24 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | がんの治療のためのハロインドール大環状化合物 |
| KR20250085767A (ko) | 2022-09-29 | 2025-06-12 | 광조우 조요 파마테크 컴퍼니 리미티드 | 거대고리 유도체 및 이의 적용 |
| CN120813588A (zh) | 2023-02-14 | 2025-10-17 | 豪夫迈·罗氏有限公司 | 用于治疗癌症的三环化合物 |
| AU2024241633A1 (en) * | 2023-03-30 | 2025-11-06 | Revolution Medicines, Inc. | Compositions for inducing ras gtp hydrolysis and uses thereof |
| TW202446387A (zh) * | 2023-04-06 | 2024-12-01 | 瑞士商赫孚孟拉羅股份公司 | 用於治療癌症之三環化合物 |
| TW202508595A (zh) | 2023-05-04 | 2025-03-01 | 美商銳新醫藥公司 | 用於ｒａｓ相關疾病或病症之組合療法 |
| US20250041295A1 (en) * | 2023-07-14 | 2025-02-06 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2025162395A1 (zh) * | 2024-02-01 | 2025-08-07 | 山东先声生物制药有限公司 | 吲哚衍生物作为ras抑制剂及其应用 |
| CN119431325A (zh) * | 2024-10-31 | 2025-02-14 | 诚达药业股份有限公司 | 一种3-（1h-吡唑-1-基）氮杂环丁烷类化合物及其合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021012057A2 (pt) | 2018-12-21 | 2021-10-19 | Revolution Medicines, Inc. | Compostos que participam de ligação cooperativa e usos dos mesmos |
| DE102019122206B4 (de) | 2019-08-19 | 2021-07-08 | Webasto SE | Dachmodul zur Bildung eines Fahrzeugdachs mit Umfeldsensor |
| TW202132316A (zh) | 2019-11-04 | 2021-09-01 | 美商銳新醫藥公司 | Ｒａｓ抑制劑 |
| IL322454A (en) | 2019-11-04 | 2025-09-01 | Revolution Medicines Inc | ras inhibitors |
| AU2020377925A1 (en) | 2019-11-04 | 2022-05-05 | Revolution Medicines, Inc. | Ras inhibitors |
| CA3194067A1 (en) | 2020-09-15 | 2022-03-24 | Revolution Medicines, Inc. | Ras inhibitors |
-
2022
- 2022-05-25 AU AU2022281343A patent/AU2022281343A1/en active Pending
- 2022-05-25 WO PCT/US2022/030823 patent/WO2022251292A1/en not_active Ceased
- 2022-05-25 TW TW111119516A patent/TW202313631A/zh unknown
- 2022-05-25 CA CA3219533A patent/CA3219533A1/en active Pending
- 2022-05-25 CN CN202410561373.XA patent/CN118557730A/zh active Pending
- 2022-05-25 MX MX2023013912A patent/MX2023013912A/es unknown
- 2022-05-25 KR KR1020237044138A patent/KR20240026526A/ko active Pending
- 2022-05-25 JP JP2023572737A patent/JP2024521774A/ja active Pending
- 2022-05-25 CN CN202280050079.1A patent/CN117715658A/zh active Pending
- 2022-05-25 IL IL308771A patent/IL308771A/en unknown
- 2022-05-25 EP EP22731928.2A patent/EP4346898A1/en active Pending
-
2023
- 2023-11-22 US US18/518,027 patent/US20240277796A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024521774A5 (https=) | ||
| JP2024512767A5 (https=) | ||
| AU2016202439B2 (en) | Haloalkyl heteroaryl benzamide compounds | |
| JP2024521920A5 (https=) | ||
| TWI554504B (zh) | 雙效化合物、包含其之醫藥組合物、其製備方法及其用途 | |
| JP2010501478A5 (https=) | ||
| JP2023515617A5 (https=) | ||
| JP2023529908A5 (https=) | ||
| JP2008510828A5 (https=) | ||
| JP2014500322A5 (https=) | ||
| JP2023515618A5 (https=) | ||
| US20120108592A1 (en) | Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viruses | |
| JP2025510074A5 (https=) | ||
| ZA200403685B (en) | Cannabinoid receptor ligands. | |
| TW200911239A (en) | Alkylsulfonyl-substituted thiazolide compounds | |
| JP2008526761A5 (https=) | ||
| TW200301698A (en) | Acridone inhibitors of IMPDH enzyme | |
| CA2494832A1 (en) | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | |
| JPS59501362A (ja) | 二環式窒素複素環エ−テルおよびチオエ−テルおよびその製薬的使用 | |
| JP2008546770A5 (https=) | ||
| JP2024520395A5 (https=) | ||
| US5288719A (en) | 2-,3-,8-and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating osteoporosis | |
| JP2009517417A (ja) | Ｃｒｔｈ２レセプター活性を有するオキサジアゾール誘導体類 | |
| RU2004119963A (ru) | Ингибиторы вич интегразы | |
| WO2013071694A1 (zh) | 噁唑类化合物及其制备方法、药物组合物及其用途 |